Your browser doesn't support javascript.
loading
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.
Takahashi, Shin; Sakamoto, Yasuhiro; Denda, Tadamichi; Takashima, Atsuo; Komatsu, Yoshito; Nakamura, Masato; Ohori, Hisatsugu; Yamaguchi, Tatsuro; Kobayashi, Yoshimitsu; Baba, Hideo; Kotake, Masanori; Amagai, Kenji; Kondo, Hitoshi; Shimada, Ken; Sato, Atsushi; Yuki, Satoshi; Okita, Akira; Ouchi, Kota; Komine, Keigo; Watanabe, Mika; Morita, Satoshi; Ishioka, Chikashi.
Affiliation
  • Takahashi S; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
  • Sakamoto Y; Department of Clinical Oncology, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
  • Denda T; Department of Medical Oncology, Osaki Citizen Hospital, Miyagi, Japan.
  • Takashima A; Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan.
  • Komatsu Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Nakamura M; Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Hokkaido, Japan.
  • Ohori H; Aizawa Comprehensive Cancer Center, Aizawa Hospital, Nagano, Japan.
  • Yamaguchi T; Department of Medical Oncology, Japanese Red Cross Ishinomaki Hospital, Miyagi, Japan.
  • Kobayashi Y; Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Baba H; Gastroenterology and Medical Oncology, KKR Sapporo Medical Center, Hokkaido, Japan.
  • Kotake M; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Amagai K; Department of Surgery, Kouseiren Takaoka Hospital, Toyama, Japan.
  • Kondo H; Division of Gastroenterology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan.
  • Shimada K; Division of Gastroenterology, Tonan Hospital, Hokkaido, Japan.
  • Sato A; Department of Internal Medicine, Division of Medical Oncology, Showa University Koto Toyosu Hospital, Tokyo, Japan.
  • Yuki S; Department of Medical Oncology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Okita A; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan.
  • Ouchi K; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
  • Komine K; Department of Clinical Oncology, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
  • Watanabe M; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
  • Morita S; Department of Clinical Oncology, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
  • Ishioka C; Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.
Cancer Sci ; 112(4): 1567-1578, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33548159

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Irinotecan / Oxaliplatin Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2021 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Irinotecan / Oxaliplatin Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2021 Type: Article Affiliation country: Japan